SIZE GLOBAL PURCHASING
1 mg, 5 mg, 10 mg, 100mg , 500mg, 1kg
Appearance: white powder
Package: 1kg/ Aluminum foil bag
Application: Research purpose
Production Capacity: 500 Kilogram/Month
Storage: Kept in a cool, dry and ventilated place
It is also known as β-keto-N-methylbenzodioxolylbutanamine (bk-MBDB), is an entactogen, psychedelic, and stimulant of the phenethylamine chemical class. It is the β-keto analogue of MBDB.
It has been defined as an entactogen, stimulant, and psychedelic. It belongs to the phenethylamine class. Butylone is also said to be a β-keto analog of MBDB. Butylone has a relationship to another research chemical – MBDB. Some chemical suppliers of bk-MBDB say they have received some reports from people who take this research chemical orally and in rare cases nasally to achieve special state of consciousness usually associated with drugs.
It was first synthesized by Koeppe, Ludwig, and Zeile which is mentioned in their 1967 paper. It remained an obscure product of academia until 2005 when it was synthesized by a chemical supply company, and has since continued to be sold as a research chemical. It has since been explored as a possible entheogen. Butylone shares the same relationship to MBDB as methylone does to MDMA (“Ecstasy”). The dosage range is not fully understood but seems to be lower than for MBDB. Formal research on this chemical was first conducted in 2009, when it was shown to be metabolized in a similar manner to related drugs like methylone.
Buy Butylone (bk-MBDB) Online
The most common metabolite is the 4-OH-3-MeO metabolite. The metabolites containing a hydroxyl-group would be excreted as their conjugates in urine
There are three major metabolic pathways of bk-MBDB as shown in the figure. As result of demethylenation followed by O-methylation bk-MBDB metabolises into 4-OH-3-MeO and 3-OH-4-MeO metabolites in human urine. The second pathway is a β-ketone reduction into β-ketone reduced metabolites. The third pathway is a N-dealkylation into N-dealkylmetabolites.